About DeVoro Medical
DeVoro Medical is a Healthcare company based in Fremont (United States) founded in 2018 by Michael P Wallace, and was acquired by Boston Scientific in September 2021. Medical devices for treating cardiac diseases are developed. DeVoro Medical has raised $18 million across 1 funding round from investors including Boston Scientific. Its chief executive, as recorded, is Michael P Wallace. DeVoro Medical offers products and services including WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Boston Scientific Corporation. Its competitors include Tactile Medical, enVVeno Medical and Veniti; 2 of its 3 listed competitors have raised funding.
Company details
DeVoro Medical was founded in 2018 and is located in Fremont, United States. Medical devices targeted at cardiac disease treatment are developed by the company within the healthcare sector. Operations center on smart products for the peripheral thrombectomy area, utilizing a novel flow restoration technology. Blood flow in affected body regions is restored through these devices, supporting clinical interventions in cardiovascular care.
- Headquarters Fremont, United States
- Founders Michael P Wallace
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website devoromedical.com
- Social LinkedIn X Facebook Instagram
- Acquired by Boston Scientific (Sep 2021)
- Legal Name Boston Scientific Corporation
- Total Equity Funding$18M (USD)
in 1 rounds
- Latest Funding Round$18M (USD), Series B
Jul 2020
- Investors
- Acquired byBoston Scientific
(Sep 2021)
Products & Services of DeVoro Medical
DeVoro Medical offers a comprehensive portfolio of products and services, including WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System.
Removes blood clots in arterial and venous systems
Treats thromboemboli with ultrasound technology
Clears clots in blood vessels efficiently
Funding Insights of DeVoro Medical
DeVoro Medical has successfully raised a total of $18M through 1 strategic funding round. The most recent funding activity was a Series B round of $18 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $18M
- Total Rounds 1
- Last Round Series B — $18M
- First Round $18M
(Jul 2020)
All 1 funding rounds of DeVoro Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $18M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in DeVoro Medical
DeVoro Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States |
Investor details for DeVoro Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DeVoro Medical
1151 people are tracked at DeVoro Medical (316 in leadership, 9 in board & advisors, 826 in team).
| Name | Role | Group |
|---|---|---|
Michael P Wallace | Co-Founder & CEO | Leadership |
Augusto Chaves | IT PMO & Finance Head | Leadership |
Genevieve Morrison | IT Director, Acquisition & Integrations | Leadership |
David Sapienza | VP Global Operation Distribution And Logistics | Leadership |
Nikunj Murgai | Director, IT | Leadership |
Jodi Eddy | Senior Vice President, Enterprise Services and Digital Officer | Leadership |
Siri Thompson | Vice President, Program Management LAAC | Leadership |
Lance Bates | SVP & President, Interventional Cardiology Therapies | Leadership |
Alex Pflugfelder | Director - Upstream EP Marketing, EP Commercial Development Team | Leadership |
Sofía Leiva | HR Specialist - People Services Partner Latam | Leadership |
Zoe Heuver | Supply Chain Partner | Leadership |
Charles K. | Director, Quality | Leadership |
Ahmed Abdelaal | Chief Medical Officer | Leadership |
Lillian Kerrigan | Director Global Quality Design Controls And Acquisitions | Leadership |
Viktoriya Skuz | People Partner I | Leadership |
Kelly Schwenn | Director Of Program Management, Arden Hills And North America Manufacturing | Leadership |
Charudatta Aradhye | Associate Director, R&D | Leadership |
Sandra Nagale | Director, Digital Health Products, Platforms & AI | Leadership |
Gary Leblanc | Director Of Quality | Leadership |
Janet Bukovcan | Director, Regulatory Affairs | Leadership |
1131 more people are available in the full profile.
Complete people profiles for DeVoro Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DeVoro Medical
3 dated milestones of DeVoro Medical across 3 years, from founding to its latest funding, stage changes and deals.
- Founded DeVoro Medical is founded.
- Funding First funding round of $18.0M.
- Exit Acquired by Boston Scientific.
Competitors of DeVoro Medical
DeVoro Medical has 3 listed competitors in our database, 2 of them funded. They include Tactile Medical, enVVeno Medical and Veniti.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tactilemedical.com | 1995 | Minneapolis, United States | $23.2M | 592 | Home therapy devices for lymphedema and venous ulcers are provided. | |
| envveno.com | 1999 | Irvine, United States | 31 | Developer of medical device for the the treatment of venous diseases | ||
| veniti.com | 2010 | St. Louis, United States | $65.22M | A self-expanding stent system for chronic venous disease is developed. |
Detailed competitors of DeVoro Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as DeVoro Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Devoro Medical
Complete news archive for DeVoro Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DeVoro Medical
DeVoro Medical was founded in 2018 and raised its 1st funding round 2 years after it was founded.
DeVoro Medical is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Michael P Wallace is the CEO of DeVoro Medical, as recorded in our data. They have also founded this company.
DeVoro Medical is a funded company, having raised a total of $18M across 1 funding round to date. The company's 1st funding round was a Series B of $18M, raised on Jul 2020.
DeVoro Medical was founded in 2018 and is located in Fremont, United States. Medical devices targeted at cardiac disease treatment are developed by the company within the healthcare sector. Operations center on smart products for the peripheral thrombectomy area, utilizing a novel flow restoration technology. Blood flow in affected body regions is restored through these devices, supporting clinical interventions in cardiovascular care.
DeVoro Medical's top competitors include Tactile Medical, enVVeno Medical and Veniti.
DeVoro Medical offers WOLF Thrombectomy Platform, EkoSonic Endovascular System, and AngioJet Thrombectomy System.
DeVoro Medical has 1 investor. Key investors include Boston Scientific.
DeVoro Medical operates through Boston Scientific Corporation.
Yes. DeVoro Medical was acquired by Boston Scientific in September 2021.